Evidence map›Paper›PMID 33194615›Full record

ArticleFrontiers in oncology2020

Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study.

Gislaine Curty, Greta A Beckerle, Luis P Iñiguez, Robert L Furler, Pedro S de Carvalho, Jez L Marston, Stephane Champiat, Jonas J Heymann, Christopher E Ormsby, Gustavo Reyes-Terán and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Gislaine CurtyOncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Greta A BeckerleDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
Luis P IñiguezDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
Robert L FurlerDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
Pedro S de CarvalhoOncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Jez L MarstonDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
Stephane ChampiatDrug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif, France.
Jonas J HeymannDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States.
Christopher E OrmsbyCenter for Research in Infectious Diseases (CIENI), National Institute of Respiratory Diseases (INER), Mexico City, Mexico.
Gustavo Reyes-TeránCenter for Research in Infectious Diseases (CIENI), National Institute of Respiratory Diseases (INER), Mexico City, Mexico.
Marcelo A SoaresOncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Douglas F NixonDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
Matthew L BendallDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
Fabio E LealOncovirology Program, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Miguel de Mulder RougvieDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
Weill Cornell Medicine · USInstituto Nacional do Câncer · BRCornell University · USUniversité Paris-Saclay · FR

Funding

Human Endogenous Retroelements in HIV ImmunopathogenesisR01AI076059 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI NIXON, DOUGLAS F · 2009 to 2017
$3.9M
HIV induced anti-cancer HERV immunity in prostate, breast and colon cancersR01CA206488 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI NIXON, DOUGLAS F · 2016 to 2020
$2.2M
NCI NIH HHS R01 CA206488NIAID NIH HHS R01 AI076059
6 · The paper itself

Abstract

In people living with HIV (PLWH), chronic inflammation can lead to cancer initiation and progression, besides driving a dysregulated and diminished immune responsiveness. HIV infection also leads to increased transcription of Human Endogenous Retroviruses (HERVs), which could increase an inflammatory environment and create a tumor growth suppressive environment with high expression of pro-inflammatory cytokines. In order to determine the impact of HIV infection to HERV expression on the breast cancer microenvironment, we sequenced total RNA from formalin-fixed paraffin-embedded (FFPE) breast cancer samples of women HIV-negative and HIV-positive for transcriptome and retrotranscriptome analyses. We performed RNA extraction from FFPE samples, library preparation and total RNA sequencing (RNA-seq). The RNA-seq analysis shows 185 differentially expressed genes: 181 host genes (178 upregulated and three downregulated) and four upregulated HERV transcripts in HIV-positive samples. We also explored the impact of HERV expression in its neighboring breast cancer development genes (

Indexed as

breast cancerbreast cancer oncogenesformalin-fixed paraffin-embeddedHIVhuman endogenous retrovirusmicroenvironmentretrotranscriptometelescope software

Identifiers

PMID33194615
PMCPMC7649802
OpenAlexW3093993633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.